Skip to main content
. 2025 Jul 4;17(13):2249. doi: 10.3390/cancers17132249
ADT Androgen Deprivation Therapy
BCR Biochemical Recurrence
BMI Body Mass Index
CRPC Castration-Resistant Prostate Cancer
CT Computed Tomography
MBq Megabecquerel
MTV Metabolic Tumor Volume
OS Overall Survival
PET Positron Emission Tomography
PFS Progression-Free Survival
PSA Prostate-Specific Antigen
PSMA Prostate-Specific Membrane Antigen
RLT Radioligand Therapy
ROC Receiver Operating Characteristic
ROI Region Of Interest
SUV Standardized Uptake Value
wbTMV whole-body Total Molecular Volume
wbTL-PSMA whole-body Total Lesion PSMA